Home » Topics » BioWorld Science

BioWorld Science
RSS

BlueWillow announces interim phase I data on intranasal anthrax vaccine candidate BW-1010

Aug. 24, 2021

Biallelic mutations in DNAH10 cause male infertility with asthenoteratozoospermia

Aug. 24, 2021

Jupiter Wellness submits pre-IND meeting request for JW-100 for eczema

Aug. 24, 2021

Hepagene reports phase I data on FXR agonist HPG-1860

Aug. 24, 2021

JadiCells show promise in animal model of COPD

Aug. 24, 2021

Completed phase I studies of ME-3183 pave way for phase II studies in plaque psoriasis

Aug. 24, 2021

Bristol Myers Squibb identifies new lead BRD4 inhibitors

Aug. 24, 2021

Phase IIb study of izencitinib in ulcerative colitis misses primary endpoint

Aug. 24, 2021

First-in-human data reported for [68Ga]iPSMA-BN in healthy subjects

Aug. 24, 2021

Foghorn initiates first-in-human study of FHD-609 for synovial sarcoma

Aug. 24, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...